CL 197
Alternative Names: CL-197Latest Information Update: 09 May 2024
At a glance
- Originator HeNan Sincere Biotech Co. Ltd
- Class Antiretrovirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I HIV-1 infections
Most Recent Events
- 20 Jan 2024 HeNan Sincere Biotech Co. Ltd completes a phase I trial in HIV-1 infections (In volunteers) in China (PO) (NCT05944848)